Skip to content
People

Anastasios Polimenakos

Director at Tinos Therapeutics.

Earliest Form D on file: Apr 2026

Filed Apr 17, 2026Amendment

Tinos Therapeutics

RNA-targeted small-molecule drugs for glioblastoma

Biotech, Cambridge MA

Named, Director.

$2.25M

sold of $4M offered

Form D

Reported on an amendment to an earlier filing.

Network

At Tinos Therapeutics

2 people